Skip to main content

Post-IPO Debt Therapeutics Companies

Explore 28 therapeutics startups that raised post-ipo debt funding. Access verified founder contact information and fundraising data.

Total Companies
28
Total Funding
$329.7M
Avg Funding
$109.9M
Cities
3

Export 28 Post-IPO Debt Therapeutics Companies

Get founder emails, funding data, and company details in one CSV

Start Free Trial

Recently Funded Companies

Export
San Diego, United States
$9.7M
raised

Irras is a commercial-stage medical technology company.

Apr 2023
Post-IPO Debt

Founder Contacts

41,000+ verified contacts

Cambridge, United States
$20.0M
raised

Oncorus is an immuno-oncology company developing oncolytic viruses to fight cancer.

Apr 2022
Post-IPO Debt

Founder Contacts

41,000+ verified contacts

South San Francisco, United States
$300.0M
raised

GBT is a clinical-stage biopharmaceutical company developing a therapy for sickle cell disease.

Dec 2021
Post-IPO Debt

Founder Contacts

41,000+ verified contacts

Showing 26 to 28 of 28 companies

Ready to Connect with Post-IPO Debt Therapeutics Startups?

Get verified founder emails, funding details, and company data for 28 post-ipo debt therapeutics companies.

Get Started - Access Contact Information

Join thousands of sales teams, investors, and service providers using VCBacked